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Free to choose treatment across the eu
Follow us on twitter... @eu_consumer @eu_Health
After years of legal uncertainty, 
things have finally become 
clear for European patients who 
seek healthcare treatment in 
another member state. thanks 
to the Directive on Cross-Border 
Healthcare, they can choose 
to receive healthcare from the 
provider of their choice in another EU 
country, and claim reimbursement 
up to the cost of that treatment in 
their home country.   And that’s not 
all. The new law introduces another 
two major changes for patients.
Firstly, the need to seek prior 
authorisations for reimbursement 
becomes the exception rather 
than the rule. This cuts red tape 
and speeds up patients’ access to 
treatment. 
Secondly, it introduces a minimum 
set of rights for all EU patients: a 
right to the information they need 
to make informed decisions; a right 
to transparency on quality and 
safety standards; a right to appeal 
and seek redress; a right to a copy 
of their medical records.  The new 
national contact Points which each 
member state will establish will 
help citizens get the information 
they need. 
In addition, the EU country Directive 
confirms that medical prescriptions 
can be dispensed across EU borders, 
and brings together Member States 
to promote the development 
of interoperable eHealth tools 
and greater co-operation on the 
assessment of health technologies. 
Finally, the Directive provides for 
the creation of European reference 
networks, to encourage the pooling 
of knowledge, and access to 
highly specialized diagnosis and 
treatment, for example of rare 
diseases.
this new law marks a real 
breakthrough for patients. For 
patients to benefit from the rights 
granted by EU law, however, the law 
needs to be properly transposed 
and enforced. The ball is now in 
the court of the EU country, who 
must deliver on their obligations 
by transposing the Directive into 
national law.
Tonio Borg 
EU Commissioner for Health
toP tWeets
In the wake of the PIP breast implant 
scandal in 2010, the EU took immediate 
steps to deal with short-comings 
that the crisis had revealed. These 
measures were set out in the Joint Plan 
for immediate action agreed between 
the Commission and the Member 
States following the scandal. The plan 
covers actions by the Commission, 
Member States and the notified bodies 
themselves. Most measures have 
now been implemented or are under 
implementation.
The last essential element of the plan 
to be fulfilled was the reinforcement of 
the controls on manufacturers by fully 
competent and empowered notified 
bodies. To this end, the European 
Commission adopted in September, two 
measures focusing among others on 
the functioning of notified bodies, the 
clarification on the level of knowledge 
and experience of their staff and the 
surveillance of these bodies by the 
Member States. Both measures aim 
to maximise the potential of existing 
legislation until tighter controls 
envisaged in the Commission’s 
proposal for new legislation – currently 
negotiated in the European Parliament 
and Council - comes into place.
All medical devices, ranging from 
plasters to pace-makers, must be 
safe and serve the needs they were 
manufactured for. Some, for example, 
prosthetic heart valves, are classified as 
high risk medical devices. As such, they 
must undergo a specific round of checks 
prior to entering the market. Notified 
bodies – specific entities designated 
by Member States and notified to the 
European Commission, are in charge of 
carrying out these checks or conformity 
assessments as they are known.
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Outcome of Parliament’s vote on 
Commission’s new tobacco rules 
A Commission proposal to 
improve the functioning of the 
internal market for tobacco and 
related products was voted on  
the European Parliament on 8 
october.
MEPs voted in favour of health 
warnings covering the top 65% 
of tobacco packs and supported 
the proposed ban of products 
with characterizing flavours. They 
voted in favour of strong tracking 
and tracing system to combat 
illicit trade and strengthened 
provisions on cross-border trade. 
They rejected the proposed ban 
on slim cigarettes and voted 
against regulating e-cigarettes 
as medicines, unless they are 
presented as having curative or 
preventive properties.
The rapporteur, Ms McAvan 
(S&D) was granted a mandate 
to negotiate a first-reading 
agreement with EU ministers.
After the vote, Tonio Borg, EU 
Commissioner for Health strongly 
reaffirmed: “I am confident that 
the revised directive on tobacco 
products can still be adopted 
under the mandate of the current 
Parliament”.
On 23 July 2013, Paola Testori 
Coggi, Director General for 
Health and Consumers (SANCO), 
European Commission and 
Dominique Ristori, Director General 
of the Joint Research Centre 
(JRC) signed a memorandum of 
understanding. The agreement 
promotes cooperation between 
SANCO and JRC in programming 
and implementing EU policies in 
public health, consumer policy 
and food and feed safety.
InstItutIonal neWs Strengthening the safety of medical devices 
Animal welfare in the EU
vehicles and more skilful handling of 
animals and in 2009, testing on animals 
for cosmetic purposes was banned. A lot 
has been achieved, but more remains 
to be done to ensure the welfare of all 
animals, including pets.
The European Commission organised, 
last October 28, a first European 
conference on the welfare of dogs and 
cats. Stakeholders from Europe debated 
the welfare of companion animals in 
breeding and trading practices. A study 
into the welfare of pets in commercial 
practices was also launched. Based 
on the outcome of the study and 
the conference, the Commission will 
consider how to further improve animal 
welfare.
Achievements and future prospects
Animal welfare has been firmly rooted 
in the European Commission’s work for 
over 30 years.  It took off in earnest when 
the Lisbon Treaty recognised animals 
as sentient beings. Since then, animal 
welfare has scored major victories 
regarding farm animals, the transport 
of animals and those used in labs.
The ban on battery cages for laying 
hens, in force since 2012, has improved 
the life of 320 million hens in several 
Member States. The requirement for 
group housing of sows during pregnancy 
has, for its part, benefited 12 million 
sows. The quality of animal transport 
has steadily increased with better 
Memorandum of 
Understanding
Neven Mimica 
EU Commissioner for Consumer Policy
On 26 September, events took place 
across Europe to mark the first ever Day 
of the Ex-Smoker, an initiative of the “Ex-
Smokers are Unstoppable” campaign, and 
the first health awareness day to celebrate 
the achievements of ex-smokers.
Speaking at a public event, European 
Commissioner for Health, Tonio Borg said: 
“Tobacco remains the greatest avoidable 
health risk of our time. The Day of the 
ex-Smoker is an opportunity for us to 
acknowledge the willpower all ex-smokers 
have shown to eliminate smoking from 
their lives and embrace a smoke-free 
future. i congratulate them all.”
Celebrities, such as world renowned DJ, 
Bob Sinclar, the European Lung Foundation 
and other health organisations joined 
in the celebrations. It is hoped that the 
messages passed on the Day of the Ex-
Smoker will convince smokers that a 
life without tobacco is something worth 
striving for.
http://antibiotic.ecdc.europa.eu/
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The black symbol 
Since 1 September, a black 
inverted triangle has started to 
appear on medicines monitored 
by regulatory authorities. With 
this measure, the Commission 
aims to improve the safety of 
medicines and to highlight to 
patients, the importance of 
reporting suspected side effects 
of the medicines they are taking.
World Food Day
16 October marks World Food 
Day - an occasion to remember 
that 90 million tons of food is 
wasted annually in Europe. The 
Commission is examining how 
to better apply resources to the 
production and consumption 
of food. For more information 
read the EU roadmap to a 
resource-efficient Europe: 
Recent report on Health 
inequalities
Health inequalities have 
significantly dropped in the EU 
over the past years. However, 
there remain gaps in health 
equality between social groups 
and between regions and Member 
States. Read the full reports and 
find out more about EU action 
to address health inequalities: 
4th Journalist Workshop on 
Organ Donation
The shortfall of organs available 
for transplant is a serious issue 
in Europe. Journalists play a 
valuable role in raising awareness 
of citizens so that they consider 
donation. The 4th Workshop on 
Organ Donation allowed us to 
brief journalists on significant 
progress made recently, e.g. 
on the Action Plan on Organ 
donation and transplantation 
or the transposition and 
implementation of the Directive 
on standards of quality and 
safety of human organs intended 
for transplantation. 
Long live Ex-Smokers! 
European Antibiotic Awareness Day 2013
European Antibiotic Awareness Day 
takes place on 18 November to raise 
awareness about the threat of antibiotic 
resistance and the prudent antibiotic 
use.
resistance to antimicrobials has taken 
on serious proportions in Europe. Every 
year, 25.000 patients die of infections 
caused by antimicrobial-resistant 
bacteria. This is all the more alarming 
because antimicrobials are vital for 
modern human and veterinary medicine. 
Besides, we are currently relying on 
the last remaining generation of these 
medications.
In 2011, the Parliament called on the 
Commission to urgently establish an 
all-encompassing action plan against 
antimicrobial resistance (AMR). A 5 
year action plan was launched to be 
implemented with Member States. 
Based on a ‘one health’ approach, 
the plan promotes such actions as 
efficient communication campaigns on 
the appropriate use of antimicrobials, 
research for new effective antimicrobials 
and improved monitoring in humans 
and animals.
This year’s ECDC stakeholder event 
‘Everyone’s responsible’ (15 November 
2013) will inform the press on most 
recent antimicrobial resistance and 
antibiotic consumption trends. The 
Commission will present the most recent 
initiatives to combat antimicrobial 
resistance in the EU and will announce 
the results of the Eurobarometer 
2013 AMR on public attitudes toward 
antibiotics.
Ask the Director General - Gastein Health Forum
Behavioral Economics 
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COMING UP
25 November
Commissioner Mimica will greet 
the winners of the Consumer 
Classroom competition at the 
Berlaymont.
25 November
The EIP on Healthy Ageing 
conference will focus on the 
work undertaken in 2012 by the 
Partnership’s action groups and 
the Reference sites.
1 december
a commission decision on 
neonicotinoids enters into force.
What was your ‘take home message’ 
from this year’s European Health 
Forum on ‘Resilient and Innovative 
Health Systems in Europe’?
Firstly, I noted a shift in the way Europe’s 
health community is defining the current 
Bringing the human factor back into 
policy-making
On 30 September, the Commission 
held a high-level conference on 
behavioural sciences. At this occasion, 
we interviewed one of our speakers, 
Olivier Oullier, Professor at Aix-Marseille 
University.
Professor, what are behavioural 
sciences and how can they improve 
policy-making?
They allow us to better understand 
and act on how people make decisions, 
such as buying services. Studies have 
shown that if you want people to use 
less electricity, financial incentives 
are not the best way to change their 
behaviour. Informing them on what 
their neighbours are doing is way more 
effective.
How can policy-makers and scientists 
cooperate on policy-making?
One may think that scientists and 
policy-makers have very different goals 
and timelines. This is wrong. Their work 
is complementary. Thanks to tools like 
social media we collect unprecedented 
data. We have to put it to good use to 
test new policies before implementing 
them. I have no doubt that recent 
Commission’s initiatives in the field will 
enhance cooperation between scientists 
and policy-makers.
challenges we face. Speakers talked not 
of a ‘crisis’, as in the past, but of a ‘new 
reality’ to which our health systems 
must adjust.
The connection with our recent report 
‘Investing in Health’ could not have been 
clearer! I emphasized that investing 
in people’s health and in sustainable 
health systems was the right way 
forward! European Commissioner for 
Health, Tonio Borg further acknowledged 
that these were hard times for 
Member States and he reiterated that 
Commission was there to help.
I was pleased that the Commission’s 
messages went down well. Several 
participants said that when it comes to 
health, ‘we need more Europe’. This was 
like music to my ears.
Paola Testori Coggi 
Director General 
for Health and Consumers
